Terumo Corp.

Terumo Corp. has seen significant stock activity, reaching an intraday high while outperforming the Japan Nikkei 225 in recent trading. Despite a strong weekly gain, the company has struggled over the past year. Financially, it shows solid debt servicing capability and long-term growth potential, though it trades at a premium.

Terumo Corp. saw a significant rise in its stock price today, contrasting with the modest gain of the Japan Nikkei 225. Despite a challenging year with a notable decline, the company reported a strong EBIT to Interest ratio and a healthy annual growth rate in net sales, while facing rising raw material costs.

Terumo Corp. faced a significant decline in its stock price, reaching an intraday low amid a challenging trading session. Over the past year, the company has struggled, with notable underperformance compared to the Japan Nikkei 225. Despite this, Terumo shows long-term growth potential through increasing net sales.

Terumo Corp. has seen a significant increase in stock performance, gaining 3.05% on February 27, 2026, despite a decline in the broader market. The company reported a 10.50% annual growth in net sales and maintains a strong EBIT to Interest ratio, indicating solid debt management capabilities.

Terumo Corp. has experienced notable stock activity, achieving a 3.81% increase on February 25, 2026, despite a declining Nikkei 225. The company has shown a positive weekly trend, although it faces challenges with a significant drop over the past year and five years, while maintaining strong debt management and sales growth.

Terumo Corp., a key player in the Pharmaceuticals & Biotechnology sector, faced a decline in stock price today, reflecting ongoing market challenges. Despite recent fluctuations, the company shows strong long-term fundamentals, including a healthy EBIT to Interest ratio and consistent net sales growth, while underperforming against the Japan Nikkei 225.

Terumo Corp. faced a decline in its stock price, reflecting ongoing market challenges. Despite a modest monthly gain, the company has experienced significant year-to-date and long-term declines. However, it maintains strong fundamentals, including a healthy EBIT to Interest ratio and robust net sales growth, though its return on equity suggests a premium valuation.

Terumo Corp. has seen a rise in stock performance, reaching an intraday high and showing a weekly increase that slightly outpaces the Japan Nikkei 225. Despite a year-to-date decline and long-term underperformance, the company maintains a solid financial foundation with consistent net sales growth and a strong market capitalization.

Terumo Corp. has seen a notable increase in stock performance, reaching an intraday high of JPY 2,580.00. Despite recent gains, the company has faced challenges over the past year and three years, with significant declines compared to the Japan Nikkei 225. Terumo maintains a strong financial foundation and focuses on long-term growth.